SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034891
Filing Date
2024-11-13
Accepted
2024-11-13 16:02:35
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pirs20240930_10q.htm   iXBRL 10-Q 1091103
2 EXHIBIT 10.1 ex_741571.htm EX-10.1 97268
3 EXHIBIT 31.1 ex_722850.htm EX-31.1 8599
4 EXHIBIT 31.2 ex_722851.htm EX-31.2 9283
5 EXHIBIT 32.1 ex_722852.htm EX-32.1 4245
6 EXHIBIT 32.2 ex_722853.htm EX-32.2 4231
  Complete submission text file 0001437749-24-034891.txt   5138303

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pirs-20240930.xsd EX-101.SCH 47332
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20240930_cal.xml EX-101.CAL 29068
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20240930_def.xml EX-101.DEF 326959
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20240930_lab.xml EX-101.LAB 262453
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20240930_pre.xml EX-101.PRE 344980
66 EXTRACTED XBRL INSTANCE DOCUMENT pirs20240930_10q_htm.xml XML 686905
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 241453901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)